Donaueschingen (pta/16.05.2023/08:45 UTC+2)
Nexus AG, one of the leading European suppliers of software solutions in the healthcare sector, was able to increase its sales by 11% and EBIT by approx. 28% in the first three months of 2023. As a result, the continually positive development of sales and earnings of the last years could be continued.
Sales improved from KEUR 49,498 to KEUR 55,020 (+11.2%) in the first three months 2023. The international share of total business volume was 47.6% ((3M-2022) 48.1%) and amounted to KEUR 26,205 compared to KEUR 23,785 (3M-2022).
The consolidated earnings before interest and taxes (EBIT) rose very sharply by 28.5% to KEUR 7,688 ((3M-2022) KEUR 5,985). The consolidated earnings before taxes (EBT) developed very positively. It improved by 42.4% to KEUR 8,074 (3M 2022: 5,669).
The EBITDA increased by 14.0% to KEUR 11,602 ((3M-2022) KEUR 10,175). The EBITA increased by 21.8% from KEUR 7,161 (3M-2022) to KEUR 8,721 an the consolidated surplus rose by 28.7% to KEUR 5,654 ((3M-2022) KEUR 4,393).
As of 31/03/2023, the company had cash resources at its disposal in the amount of KEUR 129,158 (31/12/2022: KEUR 110,019). Nexus AG had equity capital amounting to KEUR 243,434 as of 31/03/2023 (31/12/2022: KEUR 238,946). Consequently, the equity capital rate is 65.3% (31/12/2022: 69.4%).
The Executive Board
|Contact Person:||Hannes Wehinger|
|Phone:||+49 771 22960-260|
|Stock Exchange(s):||Regulated Market in Frankfurt, Hamburg; Free Market in Berlin, Dusseldorf, Munich, Stuttgart|